Original Research

Published on 27 Sep 2023

177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry

in Pharmacology of Anti-Cancer Drugs

Ayman Abouzayed
Kamila Seitova
Fanny Lundmark
Vitalina Bodenko
Maryam Oroujeni
Vladimir Tolmachev
Ulrika Rosenström
Anna Orlova

Frontiers in Oncology

doi 10.3389/fonc.2023.1221103

289 views

Opinion

Accepted on 25 Sep 2023

From bench to bedside, 2-in-1 design expedites Phase 2/3 oncology drug development

in Pharmacology of Anti-Cancer Drugs

Cong Chen
Xuekui Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1251672

Case Report

Published on 22 Sep 2023

Case Report: A rare case of non-small cell lung cancer with STRN-ALK fusion in a patient in very poor condition treated with first-line ensartinib

in Pharmacology of Anti-Cancer Drugs

Guo-qiang Song
Yi-zhong Li
Weiliang Kong
Guo-qiang Hu

Frontiers in Oncology

doi 10.3389/fonc.2023.1235679

744 views

Brief Research Report

Accepted on 20 Sep 2023

Acute Low Back Pain as Infusion-related Reaction to Monoclonal Antibodies

in Pharmacology of Anti-Cancer Drugs

Pawel Majenka
Carmen Loquai
Tilman Schoening
Alexander Enk
Jessica Hassel

Frontiers in Oncology

doi 10.3389/fonc.2023.1161818

Review

Accepted on 18 Sep 2023

Natural polysaccharides exert anti-tumor effects as dendritic cell immune enhancers

in Pharmacology of Anti-Cancer Drugs

Hongtai Xiong
Xinpu Han
Liu Cai
Honggang Zheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1274048

Review

Accepted on 11 Sep 2023

The transmembrane proteins (TMEM) and their role in cell proliferation, migration, invasion, and epithelial-mesenchymal transition in cancer

in Pharmacology of Anti-Cancer Drugs

Gloria Angelina Herrena-Quiterio
Sergio Encarnacion-Guevara

Frontiers in Oncology

doi 10.3389/fonc.2023.1244740

Clinical Trial

Accepted on 07 Sep 2023

Effects of Imipramine on Cancer Patients Over-expressing Fascin1; Description of the HITCLIF Clinical Trial

in Pharmacology of Anti-Cancer Drugs

Antonio Asensi Cantó
Edith Rodríguez-Braun
María Asunción Beltrán Videla
Ana María Hurtado
Pablo Conesa-Zamora

Frontiers in Oncology

doi 10.3389/fonc.2023.1238464

Original Research

Published on 05 Sep 2023

Prognostic and therapeutic implications of iron-related cell death pathways in acute myeloid leukemia

in Pharmacology of Anti-Cancer Drugs

Tongyu Li
Tongtong Lin
Jiahao Zhu
Miao Zhou
Shufang Fan
Hao Zhou
Qitian Mu
Lixia Sheng
Guifang Ouyang

Frontiers in Oncology

doi 10.3389/fonc.2023.1222098

612 views

Original Research

Published on 29 Aug 2023

Cell cycle arrest and apoptotic studies of Terminalia chebula against MCF-7 breast cancer cell line: an in vitro and in silico approach

in Pharmacology of Anti-Cancer Drugs

Pruthvish Reddy
Sushma Pradeep
Gopinath S. M.
Chandan Dharmashekar
Disha G.
Sai Chakith M. R.
Chandrashekar Srinivasa
Ali A. Shati
Mohammad Y. Alfaifi
Serag Eldin I. Elbehairi

Frontiers in Oncology

doi 10.3389/fonc.2023.1221275

830 views

Original Research

Published on 28 Aug 2023

High quantum efficiency ruthenium coordination complex photosensitizer for improved radiation-activated Photodynamic Therapy

in Pharmacology of Anti-Cancer Drugs

Abul Kalam Azad
Lothar Lilge
Nawaid H. Usmani
John D. Lewis
Houston D. Cole
Colin G. Cameron
Sherri A. McFarland
Deepak Dinakaran
Ronald B. Moore

Frontiers in Oncology

doi 10.3389/fonc.2023.1244709

681 views

Correction

Published on 25 Aug 2023

Corrigendum: Discovery of spirooxindole-derived small-molecule compounds as novel HDAC/MDM2 dual inhibitors and investigation of their anticancer activity

in Pharmacology of Anti-Cancer Drugs

Qian Zhao
Shan-Shan Xiong
Can Chen
Hong-Ping Zhu
Xin Xie
Cheng Peng
Gu He
Bo Han

Frontiers in Oncology

doi 10.3389/fonc.2023.1259550

463 views

Correction

Published on 25 Aug 2023

Corrigendum: Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study

in Pharmacology of Anti-Cancer Drugs

Daling Dong
Shixin Zhang
Bin Jiang
Wei Wei
Chao Wang
Qian Yang
Tingzhi Yan
Min Chen
Liken Zheng
Weikang Shao

Frontiers in Oncology

doi 10.3389/fonc.2023.1275851

433 views

Editorial

Published on 23 Aug 2023

Editorial: Pharmaceutically targeting hypoxia in the breast cancer microenvironment: mechanistic and translational approaches

in Pharmacology of Anti-Cancer Drugs

Manjari Singh
Manash K. Paul
Subhadeep Roy

Frontiers in Oncology

doi 10.3389/fonc.2023.1265523

366 views

Original Research

Published on 21 Aug 2023

COVID−19 hospitalization increases the risk of developing glioblastoma: a bidirectional Mendelian-randomization study

in Pharmacology of Anti-Cancer Drugs

Jiajun Dong
Shengnan Wang
Haoqun Xie
Yanhao Mou
Hao Zhu
Yilong Peng
Jianxin Xi
Minggu Zhong
Zhengyuan Xie
Zongyuan Jiang

Frontiers in Oncology

doi 10.3389/fonc.2023.1185466

2,023 views

Brief Research Report

Published on 14 Aug 2023

Neurological adverse events of mitotane in adrenocortical carcinoma: results of a pilot study

in Pharmacology of Anti-Cancer Drugs

Marilda Mormando
Edvina Galiè
Marta Bianchini
Rosa Lauretta
Giulia Puliani
Antonio Tanzilli
Umberto Anceschi
Giuseppe Simone
Gianluca Petreri
Giuliana Graziano

Frontiers in Oncology

doi 10.3389/fonc.2023.1222002

552 views

Review

Published on 10 Aug 2023

A new approach to overcoming resistance to immunotherapy: nanotechnology

in Pharmacology of Anti-Cancer Drugs

Jiangbo Shao
Ying Jin
Chunxiang Jin

Frontiers in Oncology

doi 10.3389/fonc.2023.1210245

523 views

Navigation group

Articles

177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry

From bench to bedside, 2-in-1 design expedites Phase 2/3 oncology drug development

Case Report: A rare case of non-small cell lung cancer with STRN-ALK fusion in a patient in very poor condition treated with first-line ensartinib

Acute Low Back Pain as Infusion-related Reaction to Monoclonal Antibodies

Natural polysaccharides exert anti-tumor effects as dendritic cell immune enhancers

The transmembrane proteins (TMEM) and their role in cell proliferation, migration, invasion, and epithelial-mesenchymal transition in cancer

Effects of Imipramine on Cancer Patients Over-expressing Fascin1; Description of the HITCLIF Clinical Trial

Prognostic and therapeutic implications of iron-related cell death pathways in acute myeloid leukemia

Cell cycle arrest and apoptotic studies of Terminalia chebula against MCF-7 breast cancer cell line: an in vitro and in silico approach

High quantum efficiency ruthenium coordination complex photosensitizer for improved radiation-activated Photodynamic Therapy

Corrigendum: Discovery of spirooxindole-derived small-molecule compounds as novel HDAC/MDM2 dual inhibitors and investigation of their anticancer activity

Corrigendum: Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study

Editorial: Pharmaceutically targeting hypoxia in the breast cancer microenvironment: mechanistic and translational approaches

COVID−19 hospitalization increases the risk of developing glioblastoma: a bidirectional Mendelian-randomization study

Neurological adverse events of mitotane in adrenocortical carcinoma: results of a pilot study

A new approach to overcoming resistance to immunotherapy: nanotechnology